In the second instalment of this episode the panel tackles the trickiest questions: What kind of data are iPads collecting? What does physician adoption of iPhones & iPads mean for pharma? Can iPads actually reverse the trend toward shrinking access? Tune in and find out.

August 3, 2011
Trends in Pharmaceutical Research
Ken Kaitin, director and research professor at the Tufts Center for the Study of Drug Development discusses the role of universities and industry in early stage research and development for biotech and pharmaceutical companies.

August 10, 2011
Strategic Shire
Pharma Faceoff talks one on one with Renee Cohen, vice president of corporate strategy at Shire about how the company is focusing on future growth and development.

August 17, 2011
Sanofi’s Commitment to R&D
Dr. Ray Jupp VP of the fibrosis and wound repair therapeutic strategic unit at Sanofi talks one on one about research and development and the promise of botanical compounds.